Chelain Goodman, MD PhD (@chelaing) 's Twitter Profile
Chelain Goodman, MD PhD

@chelaing

Assistant Professor of Breast Radiation Oncology at MD Anderson Cancer Center @MDAndersonNews | Passions: translational research & #meded! Opinions are my own.

ID: 1923377256

calendar_today01-10-2013 13:06:21

4,4K Tweet

3,3K Followers

4,4K Following

Chelain Goodman, MD PhD (@chelaing) 's Twitter Profile Photo

Great to present this secondary analysis of a prospective randomized trial at SABCS showing decreased acute toxicity with VMAT vs 3D-CRT technique for patients with breast cancer receiving PMRT/RNI. An important treatment option for our patients! MD Anderson Cancer Center SABCS

Great to present this secondary analysis of a prospective randomized trial at SABCS showing decreased acute toxicity with VMAT vs 3D-CRT technique for patients with breast cancer receiving PMRT/RNI. An important treatment option for our patients! <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> <a href="/SABCSSanAntonio/">SABCS</a>
Wendy Woodward MDPhD (@ibcradiation) 's Twitter Profile Photo

Great locoregional spotlight at #SABCS24 VMAT question from Dr. Pierce about second malignancy risk. Curious how many never use VMAT to avoid this risk?

Great locoregional spotlight at #SABCS24 VMAT question from Dr. Pierce about second malignancy risk. Curious how many never use VMAT to avoid this risk?
Kim Corbin (@kimcorbinmd) 's Twitter Profile Photo

Congratulations to the Europa team for showing what we observe in #RadOnc clinic - a short course of RT is very well tolerated (QoL better than ET) and single modality may be appropriate for favorable risk patients. #SABC24

Wendy Woodward MDPhD (@ibcradiation) 's Twitter Profile Photo

Joint NRG Oncology ECOG-ACRIN study of Tam among observation arm of good risk DCIS trials showing benefits of Tam on ipsi invasive breast recurrence. #SABCS24 No contralateral benefit to Tam here. Highlights outcomes with NO therapy in this group.

Joint <a href="/NRGonc/">NRG Oncology</a> ECOG-ACRIN study of Tam  among observation arm of good risk DCIS trials showing benefits of Tam on ipsi invasive breast recurrence. #SABCS24 No contralateral benefit to Tam here. Highlights outcomes with NO therapy in this group.
Angel Montero Luis (@monthy_a) 's Twitter Profile Photo

Omission reaches also systemic treatments for breast cancer: EUROPA trial preliminary results with superb Icro Meattini presentation at #SABCS24 shows RT might be a better approach for women aged 70+ with luminal A-like early breast cancer #radonc #bcsm

Omission reaches also systemic treatments for breast cancer: 
EUROPA trial preliminary results with superb <a href="/Icro_Meattini/">Icro Meattini</a> presentation at #SABCS24 shows RT might be a better approach for women aged 70+  with luminal A-like early breast cancer #radonc #bcsm
Rad Onc Talks (@radonctalks) 's Twitter Profile Photo

Latest video in High-Yield Rad Bio series is out now! #RadBio #Radiobiology #RadiationOncology #RadOncResident #ABR #BoardExams #MedEd

Latest video in High-Yield Rad Bio series is out now! 

#RadBio #Radiobiology #RadiationOncology #RadOncResident #ABR #BoardExams #MedEd
AmyMorenoMD (@amymorenomd) 's Twitter Profile Photo

With over 16 classification systems, osteoradionecrosis (ORN) has been a challenging RT-related toxicity to diagnose and manage. I’m excited to share the multidisciplinary ORAL Consortium’s consensus guidelines on standardized data capture to enhance interoperability & diagnosis!

Chelain Goodman, MD PhD (@chelaing) 's Twitter Profile Photo

It’s an exciting time for biomarkers for breast radiotherapy! Check out our recent recap for ASTRO #ASTROnews! ⁦MD Anderson Cancer Center⁩ #bcsm #radonc astro.org/news-and-publi…

Mark Clemens MD MBA FACS (@clemensmd) 's Twitter Profile Photo

We’re hiring! MD Anderson Cancer Center seeks a visionary Chair of Breast Medical Oncology to lead cutting-edge patient care and research. Ready to shape the future of breast cancer care? Learn more & apply: jobs.mdanderson.org/Search/JobDeta… Oncology Leadership #EndCancer #OncSurgery

We’re hiring! <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> seeks a visionary Chair of Breast Medical Oncology to lead cutting-edge patient care and research. Ready to shape the future of breast cancer care? Learn more &amp; apply: jobs.mdanderson.org/Search/JobDeta… Oncology Leadership #EndCancer #OncSurgery
Jane Jomy (@janejomy) 's Twitter Profile Photo

Exciting presentation by Dr. Goodman Chelain Goodman, MD PhD demonstrating a ⬆️ rate of CTC clearance following neo & adjuvant radiotherapy in non-metastatic T3+ and/or N+ BC - looking forward to the next phase to assess CTC’s potential as a surrogate survival endpoint #ESTRO25 ESTRO

Exciting presentation by Dr. Goodman <a href="/ChelainG/">Chelain Goodman, MD PhD</a> demonstrating a ⬆️ rate of CTC clearance following neo &amp; adjuvant radiotherapy in non-metastatic T3+ and/or N+ BC - looking forward to the next phase to assess CTC’s potential as a surrogate survival endpoint #ESTRO25 <a href="/ESTRO_RT/">ESTRO</a>